A total of 95 Kl Escherichia coli strains of the 0 (lipopolysaccharide) serotypes 01, 07, or 018 had been analyzed previously for the ability to cause bacteremia after colonizing the gut of newborn rats. In this study, these strains were tested for their resistance to the bactericidal activity of rat serum. All strains that had caused bacteremia in a high percentage of the inoculated rats were able to survive for several hours in 90% adult rat serum. With only a few exceptions, 07:K1 and 018:K1 strains were serum resistant and virulent, whereas 01:K1 strains were serum sensitive and avirulent. Serum sensitivity was due to the classical complement pathway. Kl strains of all three 0 serotypes were resistant to the alternative complement pathway. 07:K1 and 018:K1 cells were killed efficiently after the classical pathway was triggered by specific antilipopolysaccharide antibodies. However, killing of 01:K1 bacteria by the classical pathway system did not require antibodies. Isolated 01-lipopolysaccharide fixed complement more efficiently than did isolated 07-or 018-lipopolysaccharide, suggesting that the differences in the chemical structure of the 0 antigens are responsible for the observed differences in complement sensitivity. In combination with epidemiological data, the results indicate that antibody-independent classical pathway activation provides an important defense mechanism for newborns against certain gram-negative infections.
Escherichia coli strains of the Ki capsular serotype represent 80% of all E. coli strains isolated from cases of meningitis in newborns (23, 25) . They are also frequently isolated from feces of healthy individuals as well as from cases of urinary tract infections and septicemia (data summarized in references 22 and 23) . Most of these Kl isolates belong to a limited spectrum of O-lipopolysaccharide (LPS) antigen types (18) . In three previous studies (1, 12, 22) , we have described biochemical and virulence properties of a large number of different Kl strains of the common LPS types 01, 07, and 018. These strains had been obtained from different sources and had been isolated from diseased and healthy individuals. It appeared that most of these strains belong to a limited number of clones spread over Europe and the United States. One predominant clone was detected among 07:K1 strains, two subclones were detected among 018:K1 strains, and two unrelated clones were detected among 01:K1 isolates (1, 12) .
Distinct differences were observed between these groups when they were tested for the ability to cause bacteremia after colonizing the gut of newborn rats. Although most of the 018:K1 and 07:K1 strains were virulent, bacteremia was only rarely caused by 01:K1 bacteria, irrespective of the clonal descent- (22) . A more detailed analysis of the different steps of the infection process showed that avirulent 01:K1 and virulent 07:K1 and 018:K1 strains colonize the gut and translocate to the mesenteric lymph nodes with comparable efficiency. Further experiments suggested that the strains that caused bacteremia were able to multiply directly in the bloodstream of the infected animals, whereas the 01:K1 bacteria were incapable of such multiplication (22) .
An analysis of published epidemiological data (Table 4 in reference 22) revealed that these serotypes were all common among fecal isolates. However, similar to their differing virulence in the rat model, 07:K1 and 018:K1 bacteria are common and O1:K1 bacteria are relatively rare among isolates from cases of meningitis in newborn children (22) . Kl strains are less common among E. coli strains isolated from cases of adult septicemia, and a higher proportion of these Kl isolates carry the 01 antigen. 018:K1 bacteria are rare and 01:K1 (and 07:K1) bacteria are common among isolates from pyelonephritis (12) . These groups of Kl bacteria thus seem to differ in the type of disease they cause rather than to represent virulent versus avirulent isolates.
Due to the differing ability of 01:K1, 07:K1, and 018:K1 bacteria to cause meningitis in newborns and to multiply in the bloodstream of newborn rats, experiments were initiated to determine whether these differences in virulence correlate with differences in serum sensitivity. It is commonly assumed that resistance to being killed by the serum complement system is an important virulence determinant of invasive gram-negative bacteria (for a review see reference 27). For example, complement-dependent bactericidal activity is apparently critical for the defense of the host against invasive Neisseria species (16) . There are, however, only limited data available about the relative importance of antibodies, complement, and phagocytes for host defense in many other invasive bacterial diseases.
The bactericidal effects of serum are mediated by the activated components of either the classical or the alternative complement pathway. Both pathways lead to the generation of the membrane attack complex (MAC), which is responsible for membrane alterations that culminate in cell death. The alternative pathway has been shown to be activated by a number of bacterial organisms in the complete absence of antibodies (24, 27) and can thus provide the nonimmune host with a natural defense against certain microbial infections. Whereas the classical pathway is typically activated by immune complexes, it has been shown recently that antibody-independent activation of the classi-SERUM SENSITIVITY OF E. COLI 685 cal pathway by microorganisms can occur (5). However, it has been suggested that this type of activation, is relevant only for killing of rough rather than smooth strains (27) , and thus the biological significance of non-immundlogical classical pathway activation for host defense remained unclear.
One mechanismn of serum resistance seems to be due to a failure of the amphiphilic MAC to integrate into hydrophobic domains on the bacterial cell surface (8, 9) . Both the capsule and the 0 antigen seem to unspecifically reduce the sensitivity of the bacteria to the MAC (21) . In addition, the Kl capsule and certain 0 antigens seem to interfere with antibody-independent complement activation (21).
MATERIALS AND METHODS
Bacterial strains. The E. coli strains used here have been described elsewhere (1, 12, 22) in detail. Standard and exceptional strains are listed in Table 1 . The following strains (referred to by the sequential numbers used in Table 1 of reference 1) had formerly been tested in the rat bacteremia model (22) Sera. Sera were prepared by allowing freshly drawn blood to clot for 1 h at room temperature, followed by 3 h at 4°C and low-speed centrifugation. Small samples were stored at -70°C until use. Inactivated serum was obtained by heating for 30 mim at 56°C. Classical pathway activity was selectively inhibited by treatment of serum with 10 mM ethylene glycolbis(,-aminoethyl ether)-N,N'-tetraacetic acid (EGTA) and 5 mM MgC12. (12) of these preparations showed that almost all of the lipid Acore molecules were substituted with smooth long-chained oligosaccharides. O1/5-LPS yields a doublet band pattern on SDS-PAGE, whereas O1/9-LPS yields a singlet band pattern (12) .
ELISA. Microtiter plates (code no. 655101; Greiner, Nurtingen, Federal Republic of Germany) were sequentially subjected to: (i) overnight incubation at 37°C with ELISA buffer containing 5 jig of LPS per ml, (ii) three washes with ELISA buffer, (iii) incubation with ELISA buffer containing 0.5% bovine serum albumin for 1 h at room temperature, (iv) three washes with ELISA buffer, (v) incubation with serial dilutions of rat serum in ELISA buffer containing 0.5% bovine serum albumin for 4 to stop the reaction. The optical density was measured by using a Microelisa Autoreader MR 580 (Dynatech, Plochingen, Federal Republic of Germany) at a wavelength of 490 nm and by using as control a well treated identically except that no rat serum had been added.
Blotting procedure. Crude membrane fractions were obtained by sonication (80 s at 50% cycle, Branson cell disrupter B-30; Branson Sonic Power Co., Danbury, Conn.) from bacteria grown to mid-exponential phase in L broth. Unbroken cells were removed by low-speed centrifugation, and the membranes were pelleted by high-speed centrifugation as described previously (1). SDS-PAGE was carried out as described previously (12) by using a discontinuous gel system in slab gels containing 4 M urea and an exponential gradient of acrylamide (7.5 to 25% [wt/vol] ) and bis-acrylamide (0.2 to 0.67% [wt/vol]). The gels were subjected to electrophoretic transfer with a TE42 Transphor Electrophoresis Unit (Hoefer Scientific Instruments, San Francisco, Calif.). For electrophoretic transfer, a sandwich was constructed consisting of a perforated polyvinyl chloride sheet, a Dacron sponge, three layers of filter paper, a nitrocellulose filter membrane (NCM) (BA 85; 0.45 Rm; Schleicher and Schiill, Federal Republic of Germany), and a second layer of filter paper, sponge, and polyvinyl chloride sheet. Transfer was accomplished in a chamber filled with transfer buffer at ca. 6 V/cm (1 A) for 2 h.
After transfer, NCM strips at room temperature were sequentially subjected to: (i) incubation with blotting buffer containing 1% casein for 1 h, (ii) incubation with diluted rat serum for 2 h, (iii) three washes with blotting buffer, (iv) incubation with conjugated goat anti-rat IgG antibodies (IgG fraction of antiserum, alkaline phosphatase conjugated, dilution factor 1:1,000; Sigma) for 2 h, (v) five washes with blotting buffer, and (vi) one final wash with staining buffer. The NCM strips were stained by incubation at 37°C in staining solution for 2 h.
Detection of precipitating antibodies by bacterial agglutination. Bacteria grown overnight in L broth were incubated in a boiling water bath for 2 h. A 0.2-ml portion of the suspension was mixed in a glass test tube with 0.2 ml of serial dilutions of antiserum in 0.15 M NaCl. The sealed tubes were incubated for 20 h at 50°C and examined for agglutination. Agglutinated material should remain as a suspension of particles when the tube is agitated.
Bactericidal assay. Bacteria were growth in L broth at 37°C to a density of 108 cells per ml, washed with and diluted in PBS at room temperature, and incubated in 90% serum at 37°C. The viable cell counts were determined by plating serial dilutions of the reaction mixtures on L broth agar plates. In some experiments monoclonal rat IgM specific for the 018 antigen (21; G. Pluschke and M. Achtman, manuscript in preparation) was added to the assay mixture (final concentration 20 Rg per ml). The killing experiments were performed at least three times (see Fig. 1, 2, 3 , and 5). Only minor differences in the time course of killing were observed in the different experiments.
IComplement fixation assays. A 90-p.l portion of serum was mixed with 10 RI of isolated LPS suspended in distilled water. After incubation of the mixtures for 1 h at 37°C, residual complement activity was determined as described previously (13) (Fig. 1, curve C ) and the 018:K1 bacteria (curve B) were able to multiply, but the 01:K1 cells were killed after a delay of about 1 h (curve E). Resistance of 01:K1 bacteria to heat-inactivated serum (curve A) indicated that heat-labile complement components were required for killing. Chelation of Ca2+ ions by addition of MgEGTA also abolished the bactericidal effect (curve D), suggesting that the classical complement pathway component Cl was involved in complement killing by N-RS. Similar to these results, O1:K1 cells were also sensitive to normal human and guinea pig sera but resistant to C2-deficient human and C4-deficient guinea pig sera, which lack classical pathway activity (21) . A total of 95 different O1:K1, 07:K1, and 018:K1 strains, analyzed previously for the ability to cause bacteremia after colonizing the gut of newborn rats (22) Table 1 ). In contrast, all 34 01:K1 strains that were avirulent in the infant rat model (22) were also serum sensitive. This group of strains comprised members of both unrelated O1:K1 clones (1) and two clonal exceptions (no. 22 and 58, see Table 1 ).
The observed bactericidal effect was not strongly affected by the initial bacterial concentration. 01:K1 cells were also killed when incubated at high cell densities (106 cells per ml) and resistant 018:K1 and 07:K1 strains multiplied even when they were incubated at initial cell densities as low as 102 cells per ml. The same pronounced differences in sensitivity of 01:K1 versus 07:K1 and 018:K1 bacteria were also observed when GF-RS or sera from rats raised at other breeding colonies were used (data not shown).
Antibody-mediated killing of KI E. coli strains. 018:K1 bacteria resistant to N-RS died when monoclonal rat IgM specific for the 018 antigen was added (Fig. 2, curve C) . 07:K1 bacteria (curve B) were not killed in the presence of these anti-018 antibodies. The effect on 018:K1 bacteria was not caused by agglutination of the cells, because addition of the antibodies resulted in no decrease in viable count when heated N-RS, which lacks complement activity, was used (curve A). 018:K1 bacteria thus are not intrinsically resistant to killing by the MAC generated upon activation of complement by immune complexes. Similar results were previously obtained with guinea pig serum (21) .
Killing was also found when Kl bacteria were incubated in I-RS obtained from rats that had been immunized with boiled bacteria. 018:K1 cells were killed by 018-I-RS (Fig. 3 , curve E) but not by 07-I-RS (curve A), N-RS (curve B), or 01-I-RS (not shown). As cells were killed by 07-I-RS but not by 018-I-RS or by 01-1-RS (data not shown). Thus, strains resistant to N-RS were killed only by immune sera raised against boiled bacteria of the homologous 0 antigen type. Ol:K1 cells were sensitive to all three I-RS, and killing of these bacteria was not enhanced in 01-I-RS as compared with N-RS.
A plausible explanation of these results was that the observed classical complement pathway killing of 01:K1 bacteria by sera from nonimmunized rats was triggered by natural antibodies specific for the 01 antigen. Therefore attempts were made to detect and quantitate LPS-specific antibodies.
Antibody content of rat sera. The titer of precipitating anti-0 antigen antibodies was determined by 0 agglutination tests with boiled bacteria. Whereas N-RS and GF-RS caused no agglutination of boiled 01, 07, or 018 bacteria, all three I-RS reacted specifically up to a dilution of 1:512 with cells of the corresponding 0 antigen type.
IgG and IgM antibodies that can bind to LPS were quantitated separately by ELISA. LPS extracted with hot phenol water was adsorbed onto microtiter plates. Serial dilutions of rat sera (first antibody), diluted goat anti-rat-IgG or goat anti-rat-IgM serum (second antibody), and peroxidase-labeled rabbit anti-goat-IgG antibodies (third antibody)
were sequentially added to the wells, and the amount of third antibody bound was measured by enzymatic assay. Only weak responses (probably caused by unspecific binding of rat immunoglobulins to the wells) were observed when N-RS was assayed against the antigens 01-LPS (Fig. 4A, curve a;  Fig. 4C , curve a), 018-LPS (Fig. 4B, curve a; Fig. 4D , curve a), or 07-LPS (not shown). The responses for all three LPS types were comparable. Addition of 1% I-RS to N-RS resulted in a distinct response to the corresponding LPS (b curves). Low values similar to those obtained with N-RS were detected with GF-RS against all three LPS antigens or when the immune sera were tested against the heterologous antigens. Figure 5 shows that 01:K1 cells were killed more efficiently by N-RS alone (curve D) than 018:K1 cells were killed by N-RS containing 10% 018-I-RS (curve C). Addition of 1% 018-I-RS to N-RS caused a distinct response in the ELISA (Fig. 4) but did not affect the growth of 018:K1 cells (Fig. 5,  curve B) . Thus, the bactericidal assay is much less sensitive than the ELISA for anti-LPS antibodies. Because no anti-01-LPS antibodies were detected by the ELISA in N-RS or GF-RS, it would be necessary to invoke an exquisite sensitivity of 01:K1 bacteria to anti-LPS antibodies to account for the bactericidal activity of N-RS or GF-RS. However, no accelerated killing was observed when anti-Ol antibodies were added to N-RS or GF-RS (see above). Thus it seems that the presence of trace amounts of anti-01-LPS antibodies cannot account for the bactericidal activity seen with these sera.
A highly sensitive blotting technique was used to investi- gate whether antibodies specific for bacterial antigens other than LPS are responsible for complement activation by 01:K1 cells in sera from nonimmune rats (Fig. 6) . A crude membrane preparation of the 01:K1 strain 41 was subjected to separation by SDS-PAGE and electrophoretic transfer to NCM. Under the conditions used, LPS was not bound to the NCM. NCM strips were sequentially incubated with rat serum and alkaline phosphatase-conjugated goat anti-rat-IgG antibodies. Binding of conjugated antibodies was monitored by staining for phosphatase activity. All three I-RS showed a strong cross-reactivity at a 1:1,000 dilution to a multitude of antigens (lanes A through C), N-RS reacted somewhat at a much higher concentration (1:50 dilution) (lane F), whereas GF-RS gave no response (lane E). Similar results were obtained with membranes of 07:K1 and 018:K1 cells and also when a double sandwich technique for the detection of rat IgM was used (data not shown). Because immune sera raised against bacteria of heterologous 0 serotype did not kill 07:K1 and 018:K1 cells, although they contained crossreactive protein antibodies, it appears that these antibodies are irrelevant to the initiation of complement killing of these smooth encapsulated bacteria. Possibly the protein antigens are not accessible when present in an intact cell membrane (shielding by capsule and LPS), or the antibodies detected have a low affinity. Although anti-Kl capsule antibodies were not assayed, such antibodies should have been equally bactericidal against all Kl strains and are probably lacking in N-RS or GF-RS. Thus GF-RS apparently contains no antibodies specific for E. coli antigens, and we conclude that the bactericidal activity of GF-RS against Ol:K1 cells (which is comparable to that of N-RS) is antibody independent. We note that colostrum-deprived calf serum, which contains only trace amounts of antibodies, is also bactericidal to O1:K1 but not to 07:K1 or 018:K1 E. coli strains (reference 21 and unpublished data).
Complement fixation by isolated LPS. Recent evidence indicates that the classical complement pathway component Cl is readily activated even in the complete absence of antibodies by a diversity of substances, including the lipid A part of LPS (5, 6). As complement resistance of Kl E. coli strains seems to be related to certain 0 antigens and 01 cells seem to activate the classical complement pathway more efficiently than do 018 bacteria (21), we tested whether 01-, 07-, and 018-LPS differ in their capacity to activate complement. Isolated LPS was incubated for 1 h in 90% GF-RS, and the residual complement activity was measured by hemolysis of sensitized sheep erythrocytes. It has been shown (12) is structurally somewhat different. Each isolated 01-LPS had a far higher anticomplementary activity than did isolated 07-or 018-LPS (Fig. 7) . The 01 antigen thus seems to be directly responsible for the increased complement activation observed with 01:K1 cells.
DISCUSSION
Many gram-negative bacterial strains are generally sensitive to the bactericidal effects of vertebrate sera, whereas others are resistant, at least in the absence of specific antibodies (27) . However, no generally accepted technique has yet emerged for distinguishing serum-resistant from serum-sensitive strains. Thus, serum resistance has been claimed for laboratory strains of E. coli K-12 after the acquisition of certain plasmids, based upon a small reduction in killing by highly diluted serum. In contrast, serum sensitivity has been claimed for smooth, natural isolates that first showed a reduction in viable counts after 1 h of exposure to 90% serum (27) . We have chosen the stringent conditions recommended by Taylor (27) and have called strains resistant when they showed no reduction in viable counts after several hours of incubation in 90% serum and sensitive when the viable counts dropped to less than 5% of the initial inoculum. Most of the strains tested here fell into one of these categories, whereas a few yielded intermediate values.
A total of 95 01:K1, 07:K1, or 018:K1 E. coli strains had been analyzed previously for the ability to cause bacteremia after colonizing the gut of newborn rats (22) . These strains were tested for their resistance to serum obtained from nonimmunized adult rats. All strains that had caused bacteremia in at least 10% of the rats tested were scored as resistant or intermediate in the serum sensitivity test. No serum-sensitive strain was found which had been able to cause bacteremia. Thus, under the stringent assay conditions used, serum resistance or sensitivity correlated with virulence or lack of virulence in the animal model. A few 018:K1 strains which rarely caused bacteremia were serum (12) , and differences in capsular content thus do not seem to be responsible for the observed differences in complement sensitivity. Thus serum sensitivity or resistance correlated with the 0 serotype of these bacteria, and this correlation is a plausible explanation for the virulence differences observed in the disease model. 018:K1 and 07:K1 cells were not intrinsically resistant to the bactericidal action of the terminal MAC but were efficiently killed once the complement system was activated by addition of specific anti-LPS antibodies. In the absence of such antibodies, however, the cells were complement resistant. In a previous report (21), we showed that 018:K1 E. coli strains require both the Kl capsule and the 0-antigen for interference with non-immunological complement activation. Sialic acid seems to specifically impede alternative pathway activation by changing the affinity between certain complement components (B or H to C3b) (11, 17, 20) . Therefore strains that possess the KI (sialic acid) capsule seem to be generally resistant to killing (21) and opsonization (2, 26) by sera deficient in classical pathway activity (MgEGTA-chelated or genetically C4 or C2 deficient sera).
The data presented here and in a previous report (21) demonstrate that antibody-independent classical pathway activation accounts for complement sensitivity of 01:K1 cells. Although it is now known that the ability to activate the classical pathway in the complete absence of antibodies is shared by many substances, it is unclear which structural characteristics lead to initiation and amplification of this type of activation (4, 5, 10, 14) . Whereas deeper structures on the cell surface seem to be responsible for non-immunological classical pathway activation by rough or unencapsulated mutants (4, 21) , it appears that the 01 antigen itself activates complement efficiently and thus causes serum sensitivity of wild-type 01:K1 E. coli bacteria. It should be noted that 01:K1 cells have as much LPS as do 07:K1 or 018:K1 cells and that the length distribution of LPS in 01:K1 cells is the same as that of 07:K1 cells and only slightly different from that of 018:K1 cells (12) . Thus the chemical composition of the LPS rather than the chain length or amount seems to be responsible for the observed differences in complement activation. The LPS of the two 01 clonal groupings is, however, structurally and antigenically somewhat different (12; M. Achtman, A. Moll, B. Kusecek, G. Pluschke, B. Slawig, B. Jann, and K. Jann, manuscript in preparation). Furthermore strain 22 (01:K1), whose LPS is dissimilar to that of the clonal groupings (12) , was also avirulent and complement sensitive. The differences in the structural composition of these three 01-LPS antigens are currently unknown but do not seem to be relevant for complement activation.
The fact that one moderately complement-resistant 01:K1 strain was found that synthesized normal amounts of capsule and LPS (12) indicates that still other cell structures may be able to modulate the nature of the interactions of complement components with bacterial cell surfaces. Although many of the bacteria tested here possess F type or CoIV plasmids (1) , this does not seem to be very relevant to the situation described here: some O1:K1 and 018:K1 strains of membrane protein pattern 9, which are indistinguishable in many independent properties (1), also contain an identical F type plasmid. Plasmid-free derivatives did not differ in their complement resistance properties from those of their parents (manuscript in preparation).
The difference in sensitivity of O1:K1 versus 07:K1 or 018:K1 E. coli strains to classical pathway killing was found in rat, guinea pig, and calf sera (21) , demonstrating that this difference is related to mechanisms that are not only rat specific. Furthermore, a comparable difference was found upon analysis of the relative frequency of isolation of 01:K1, 07:K1, and 018:K1, bacteria from cases of meningitis in newborn children (22) , suggesting that antibody-independent classical pathway activation protects newborns against meningitis due to 01:K1 bacteria. Whereas this activation initiates killing of O1:K1 cells by the MAC in adult rat serum, opsonization leading to phagocytotic ingestion may be more important in newborns (3; Pluschke and Achtman, manuscript in preparation), where the complement system is not yet fully developed (15, 19) .
The results presented here and in previous reports (21) indicate that the chemical compositions of both the capsular polysaccharide and the 0 antigen determine the degree of complement activation and thus the virulence of E. coli strains in meningitis in newborns. The ability to impede alternative pathway activation may well be the major reason for the clear dominance of Kl strains in meningitis in newborns (7, 23; 25) . Differing capacities for antibodyindependent classical pathway activation seem to account for 0 antigen-related differences in virulence of Kl strains.
Additional immune mechanisms (transfer of maternal antibodies) may protect most newborns colonized by potentially invasive E. coli bacteria within the first days of life against sepsis and meningitis. In fact, LPS-specific antibodies not only initiate killing of otherwise complement-resistant Kl strains in adult rat serum but also protect newborn rats against bacterial invasion (Pluschke and Achtman, manuscript in preparation).
